The FGFR1 Gene Osteoglophonic Dysplasia Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the FGFR1 gene, which are linked to osteoglophonic dysplasia. This rare genetic disorder is characterized by abnormalities in bone growth and development, leading to distinctive facial features, dwarfism, and other skeletal anomalies. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect specific genetic alterations in the FGFR1 gene, providing crucial information for accurate diagnosis, management, and genetic counseling for affected individuals and their families. DNA Labs UAE, with its state-of-the-art facilities and expert geneticists, ensures precise and reliable test results, offering a vital tool in the understanding and treatment of osteoglophonic dysplasia.
The EYA1 Gene Otofaciocervical Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the EYA1 gene, which are known to cause Otofaciocervical Syndrome (OFCS). This condition is a rare genetic disorder characterized by a distinctive combination of facial, ear, and cervical spine abnormalities, along with possible hearing impairment. The test is crucial for accurate diagnosis, enabling targeted interventions and management strategies for affected individuals. Performed using advanced genetic sequencing technologies, this test provides a comprehensive analysis of the EYA1 gene. The cost of the test is 4400 AED, reflecting the sophisticated nature of the testing process and the invaluable insights it offers into managing the syndrome effectively.
The COL11A2 Gene Otospondylomegaepiphyseal Dysplasia Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the COL11A2 gene, which are associated with Otospondylomegaepiphyseal Dysplasia (OSMED). OSMED is a rare genetic disorder characterized by skeletal abnormalities, hearing loss, and vision problems, among other symptoms. The test plays a crucial role in confirming the diagnosis, allowing for early intervention and management of the condition.
Conducted at the state-of-the-art facilities of DNA Labs UAE, the test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for specific genetic mutations in the COL11A2 gene. The presence of these mutations confirms the diagnosis of OSMED, enabling healthcare providers to tailor treatment and management plans to the individual's needs.
The cost of the COL11A2 Gene Otospondylomegaepiphyseal Dysplasia Genetic Test is 4400 AED. This investment covers the comprehensive analysis required to detect the genetic mutations associated with the condition, offering invaluable information for affected individuals and their families. Given the complexity and rarity of OSMED, this test represents a critical step towards understanding and managing the disorder effectively.
The COL2A1 Gene Otospondylomegaepiphyseal Dysplasia Genetic Test is a specialized diagnostic tool designed to identify mutations in the COL2A1 gene, which are linked to Otospondylomegaepiphyseal Dysplasia (OSMED). OSMED is a rare genetic disorder characterized by skeletal abnormalities, hearing loss, and distinctive facial features. The COL2A1 gene plays a crucial role in the development and maintenance of the extracellular matrix of cartilage, which is essential for the proper formation of bones and other tissues. Mutations in this gene can disrupt these processes, leading to the symptoms associated with OSMED.
This test is particularly valuable for individuals who exhibit symptoms of OSMED, as well as for families with a history of the condition, as it can provide a definitive diagnosis and help guide management and treatment decisions. Early diagnosis is key to managing the condition effectively and improving the quality of life for those affected.
The test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals to ensure accurate and reliable results. The cost of the COL2A1 Gene Otospondylomegaepiphyseal Dysplasia Genetic Test is 4400 AED, reflecting the specialized nature of the test and the comprehensive analysis it entails. This investment can provide invaluable insights into the genetic underpinnings of OSMED, facilitating targeted interventions and support for affected individuals and their families.
The GLI3 Gene Pallister-Hall Syndrome Genetic Test is a specialized diagnostic examination conducted at DNA Labs UAE. This test is designed to detect mutations in the GLI3 gene, which are known to cause Pallister-Hall Syndrome (PHS). PHS is a rare genetic disorder characterized by a variety of physical anomalies, including extra fingers or toes, hypothalamic hamartoma, and other malformations affecting the development of various parts of the body.
DNA Labs UAE offers this comprehensive genetic test for individuals suspected of having PHS or for those with a family history of the condition, aiming to provide a definitive diagnosis. The test involves collecting a DNA sample, typically through a blood draw, which is then analyzed for specific mutations in the GLI3 gene that are indicative of Pallister-Hall Syndrome.
The cost of the GLI3 Gene Pallister-Hall Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the specialized nature of the test and the sophisticated technology and expertise required to accurately identify the genetic mutations associated with the syndrome. Following the test, patients receive a detailed report of the findings, which can be crucial for planning appropriate medical management and care for those affected by PHS.
The PAX2 Gene Papillorenal Syndrome Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the PAX2 gene, which are linked to Papillorenal Syndrome, a rare genetic disorder. This condition is characterized by abnormalities in the development of the eyes and kidneys, leading to a range of symptoms including visual impairment and renal dysfunction. The test is a crucial tool for confirming the diagnosis, understanding the severity, and guiding the management of the syndrome.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to detect any mutations in the PAX2 gene.
The cost of the PAX2 Gene Papillorenal Syndrome Genetic Test is 4400 AED. While the price may seem steep, the test offers invaluable insights into the genetic underpinnings of the syndrome, enabling targeted interventions and allowing families to make informed decisions about future pregnancies. It also contributes to a better understanding of the disorder, potentially paving the way for new treatments and management strategies.
The "MSX2 Gene Parietal Foramina Type 1 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the MSX2 gene, which are associated with Parietal Foramina Type 1, a rare genetic condition. This condition is characterized by the incomplete closure of the bones in the skull, leading to parietal foramina, or small holes in the parietal bones. These can vary in size and are sometimes associated with other clinical symptoms, though many individuals may remain asymptomatic.
The test is performed at DNA Labs UAE, a facility known for its advanced genetic testing capabilities. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed to detect any mutations in the MSX2 gene that indicate the presence of Parietal Foramina Type 1. This genetic test is crucial for accurate diagnosis, allowing for appropriate monitoring and management of the condition.
The cost of the MSX2 Gene Parietal Foramina Type 1 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem high, the test provides invaluable information for affected individuals and their families, enabling them to understand their genetic condition better and make informed decisions about their health and care.
The LBR Gene Pelger-Huët Anomaly Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the LBR gene, which are responsible for Pelger-Huët anomaly (PHA). This genetic condition is characterized by abnormal nuclear shape and segmentation in granulocytes, a type of white blood cell, leading to a distinctive hypolobulated appearance. These cellular abnormalities, while often benign and asymptomatic, can sometimes be indicative of more severe bone disorders or be confused with more serious hematological diseases.
DNA Labs UAE offers this precise genetic test as a part of its comprehensive portfolio, utilizing advanced genetic sequencing technologies to accurately detect the presence of mutations in the LBR gene. The test is crucial for individuals with a family history of PHA or those who exhibit hematological findings suggestive of this anomaly, as it aids in confirming the diagnosis, understanding the condition's severity, and guiding potential treatment options.
The cost of the LBR Gene Pelger-Huët Anomaly Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the meticulous process of DNA analysis, ensuring that individuals receive accurate and reliable results. Given the specialized nature of this test, it represents a critical step for affected individuals or families in managing and understanding their genetic health landscape.
The LAMC1 gene plays a crucial role in the integrity and function of cellular structures, particularly in the composition of the basement membrane, which is essential for tissue and organ stability. Mutations or variations in the LAMC1 gene have been associated with an increased risk of pelvic organ prolapse (POP), a condition characterized by the descent of pelvic organs due to weakened support structures. This condition can lead to discomfort, urinary incontinence, and a significant impact on the quality of life.
To assess the genetic risk of developing pelvic organ prolapse, DNA Labs UAE offers a specialized genetic test focused on the LAMC1 gene. This test is designed to identify specific mutations or variants within the LAMC1 gene that are linked to an elevated risk of POP. By analyzing a patient's DNA, the test can provide valuable information regarding their predisposition to this condition, enabling early intervention strategies and personalized management plans.
The cost of the LAMC1-related genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis of the LAMC1 gene to detect any genetic variations that may contribute to the development of pelvic organ prolapse. The test is conducted in a state-of-the-art laboratory by experienced genetic specialists, ensuring accurate and reliable results. Individuals who are concerned about their risk of POP, especially those with a family history of the condition, may find this test particularly beneficial for making informed decisions about their health and preventative care.
Perlman Syndrome is a rare genetic disorder characterized by overgrowth, kidney abnormalities, and an increased risk of Wilms' tumor in infancy and childhood. It is caused by mutations in the DIS3L2 gene. The DIS3L2 gene plays a crucial role in cellular RNA metabolism, and mutations in this gene lead to the abnormal development and function of various body systems.
To diagnose Perlman Syndrome, a specific genetic test targeting the DIS3L2 gene can be performed. This test involves analyzing the patient's DNA to identify mutations in the DIS3L2 gene that are associated with the syndrome. The availability of such a test is a significant step forward in the early detection and management of Perlman Syndrome, allowing for timely intervention and monitoring for potential complications.
In the UAE, DNA Labs UAE offers this specialized genetic test for Perlman Syndrome. The test cost is set at 4400 AED, reflecting the intricate processes involved in genetic analysis and the specialized expertise required to interpret the results accurately. Undergoing this test at DNA Labs UAE ensures that individuals suspected of having Perlman Syndrome or those with a family history of the disorder can receive a definitive diagnosis. This, in turn, facilitates the implementation of appropriate management strategies and supportive care to improve the quality of life for affected individuals and their families.
